Artwork

Contenuto fornito da Foresight Institute. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Foresight Institute o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Vision Weekend France: Biotech Panel

37:43
 
Condividi
 

Manage episode 405339924 series 2943147
Contenuto fornito da Foresight Institute. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Foresight Institute o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

t

Panellists: Alex Fedintsev, Leon Peshkin, Yuri Deigin, and Aleksandra Singer.

Recorded at Vision Weekend France 2023.


Key Highlights

  • They discussed the field's growth in public acceptance and funding over the past five years – they noted that, whilst reprogramming and longevity research are advancing, overall outcomes in the field haven't been as fruitful as hoped. For example, no groundbreaking concepts have emerged since reprogramming. However, they expressed optimism about the field's future, expecting gradual progress.
  • The panellists identified organ replacement, including preemptive strategies, as a key research area, as well as the potential for growth in artificially creating organs.
  • The potential integration of AI and machine learning in longevity biotech, particularly in projects like Alto Labs, was discussed.
  • They raised questions about the timeline and impact of ageing on future generations.
  • The discussion ended with an acknowledgement that, despite the optimism, much work remains in longevity biotech research.

About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 episodi

Artwork
iconCondividi
 
Manage episode 405339924 series 2943147
Contenuto fornito da Foresight Institute. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Foresight Institute o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

t

Panellists: Alex Fedintsev, Leon Peshkin, Yuri Deigin, and Aleksandra Singer.

Recorded at Vision Weekend France 2023.


Key Highlights

  • They discussed the field's growth in public acceptance and funding over the past five years – they noted that, whilst reprogramming and longevity research are advancing, overall outcomes in the field haven't been as fruitful as hoped. For example, no groundbreaking concepts have emerged since reprogramming. However, they expressed optimism about the field's future, expecting gradual progress.
  • The panellists identified organ replacement, including preemptive strategies, as a key research area, as well as the potential for growth in artificially creating organs.
  • The potential integration of AI and machine learning in longevity biotech, particularly in projects like Alto Labs, was discussed.
  • They raised questions about the timeline and impact of ageing on future generations.
  • The discussion ended with an acknowledgement that, despite the optimism, much work remains in longevity biotech research.

About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 episodi

Alle episoder

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida